NCT06040203View on ClinicalTrials.gov

Leukocyte-rich PRP or Leukocyte-free PRP vs Placebo in the Treatment of Epicondylitis

NARecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 23, 2023

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Tennis Elbow
Interventions
BIOLOGICAL

Injection of autologous leukocyte rich platelet rich plasma (LR-PRP)

Patients will be treated with a single eco-guided injection of Autologous LR-PRP in the elbow affected by epicondylitis.

BIOLOGICAL

Injection of autologous leukocyte poor platelet rich plasma (LP-PRP)

Patients will be treated with a single eco-guided injection of Autologous LP-PRP in the elbow affected by epicondylitis.

DRUG

Placebo (saline solution)

Patients will be treated with a single injections of saline solution in the elbow affected by epicondylitis.

Trial Locations (1)

40136

RECRUITING

Istituto Ortopedico Rizzoli, Bologna

All Listed Sponsors
lead

Istituto Ortopedico Rizzoli

OTHER